000 01334 a2200385 4500
005 20250516053450.0
264 0 _c20130129
008 201301s 0 0 eng d
022 _a1755-5922
024 7 _a10.1111/j.1755-5922.2011.00267.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFung, En C
245 0 0 _aStatin myopathy: a lipid clinic experience on the tolerability of statin rechallenge.
_h[electronic resource]
260 _bCardiovascular therapeutics
_cOct 2012
300 _ae212-8 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAnticholesteremic Agents
_xadverse effects
650 0 4 _aCreatine Kinase
_xmetabolism
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHydroxymethylglutaryl-CoA Reductase Inhibitors
_xadverse effects
650 0 4 _aLipid Metabolism
_xdrug effects
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMuscular Diseases
_xchemically induced
650 0 4 _aRetrospective Studies
650 0 4 _aRisk Factors
650 0 4 _aSex Factors
650 0 4 _aSimvastatin
_xadverse effects
700 1 _aCrook, Martin A
773 0 _tCardiovascular therapeutics
_gvol. 30
_gno. 5
_gp. e212-8
856 4 0 _uhttps://doi.org/10.1111/j.1755-5922.2011.00267.x
_zAvailable from publisher's website
999 _c21125955
_d21125955